Literature DB >> 19591100

Chronic obstructive pulmonary disease and risk of infection.

Peter Lange1.   

Abstract

This review article focuses on the risk of infections in patients with chronic obstructive pulmonary disease (COPD). Throughout the years there have been a number of studies describing the risk of pulmonary infections in patients with COPD, whereas only few studies have focused on the risk of infection outside the lungs. With increasing severity of COPD the risk of respiratory tract infection also increases. The impairment of the innate immune system is most likely responsible for both the colonization of respiratory tract with bacteria and for an increased risk of infection with new strains of bacteria causing acute exacerbations. Also lung infections like pneumonia, lung abscess and empyema are more often seen in patients with COPD than in healthy subjects. With regard to extrapulmonary infections, it seems that COPD patients are not at higher risk of infection compared with subjects without COPD. It is concluded that COPD is significantly associated with an increased risk of various respiratory tract infections, but not with infections outside the respiratory system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591100

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  8 in total

1.  Relation between chronic obstructive pulmonary disease and antibiotics.

Authors:  Salvador Sialer; Liapikou Adamantia; Mónica Guerrero; Antoni Torres
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

2.  Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.

Authors:  D Brask-Lindemann; P Eiken; P Eskildsen; B Abrahamsen
Journal:  Osteoporos Int       Date:  2012-11-14       Impact factor: 4.507

3.  Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance.

Authors:  Julia D Boehme; Sabine Stegemann-Koniszewski; Andrea Autengruber; Nicole Peters; Josef Wissing; Lothar Jänsch; Andreas Jeron; Dunja Bruder
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

4.  Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.

Authors:  Chih-Cheng Lai; Ya-Hui Wang; Cheng-Yi Wang; Hao-Chien Wang; Chong-Jen Yu; Likwang Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-03-08

Review 5.  Divergent Sepsis Pathophysiology in Older Adults.

Authors:  Meagan S Kingren; Marlene E Starr; Hiroshi Saito
Journal:  Antioxid Redox Signal       Date:  2021-10-01       Impact factor: 8.401

6.  Presence of lung cancer and high gender, age, and physiology score as predictors of acute exacerbation in combined pulmonary fibrosis and emphysema: A retrospective study.

Authors:  Jee Youn Oh; Young Seok Lee; Kyung Hoon Min; Gyu Young Hur; Sung Yong Lee; Kyung Ho Kang; Jae Jeong Shim
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  An examination of trends in antibiotic prescribing in primary care and the association with area-level deprivation in England.

Authors:  Katie Thomson; Rachel Berry; Tomos Robinson; Heather Brown; Clare Bambra; Adam Todd
Journal:  BMC Public Health       Date:  2020-08-03       Impact factor: 3.295

Review 8.  Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.

Authors:  Ondřej Kubeček; Pavla Paterová; Martina Novosadová
Journal:  Life (Basel)       Date:  2021-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.